| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 28 Feb 25 | VNDA Vanda Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 4.76 | 10,000 | 47.60 k | 2,361,730 |
| 27 Feb 25 | VNDA Vanda Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 4.76 | 10,000 | 47.60 k | 2,351,730 |
| 26 Feb 25 | VNDA Vanda Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 4.78 | 5,000 | 23.90 k | 2,341,730 |
| 26 Feb 25 | VNDA Vanda Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 4.75 | 5,000 | 23.75 k | 2,336,730 |
| 25 Feb 25 | VNDA Vanda Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 4.464 | 10,000 | 44.64 k | 2,331,730 |
| 18 Feb 25 | VNDA Vanda Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 450,000 | 0.00 | 2,321,730 |
